Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Apr 19:16:58.
doi: 10.1186/s12882-015-0047-z.

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis

Affiliations
Meta-Analysis

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis

Tahir Kanji et al. BMC Nephrol. .

Abstract

Background: Hyperuricemia may contribute to renal injury. We do not know whether use of treatments that lower urate reduce the progression of chronic kidney disease (CKD) and cardiovascular disease. We performed a systematic review and meta-analysis of randomized controlled trials to assess the benefits and risks of treatments that lower urate in patients with stages 3-5 CKD.

Methods: We searched MEDLINE, EMBASE, CENTRAL, Web of Science and trial registers for randomized controlled trials (RCTs) without language restriction. Two authors independently screened articles, assessed risk of bias and extracted data. Data obtained included serum uric acid, serum creatinine or other estimates of glomerular filtration rate, incidence of end-stage renal disease (ESRD), systolic and diastolic blood pressure, proteinuria, cardiovascular disease and adverse events.

Results: From the 5497 citations screened, 19 RCTs enrolling 992 participants met our inclusion criteria. Given significant heterogeneity in duration of follow-up and study comparators, only trials greater than 3 months comparing allopurinol and inactive control were meta-analyzed using random effects models. Pooled estimate for eGFR was in favour of allopurinol with a mean difference (MD) of 3.2 ml/min/1.73 m(2), 95% CI 0.16-6.2 ml/min/1.73 m(2), p = 0.039 and this was consistent with results for serum creatinine. Statistically significant reductions in serum uric acid, systolic and diastolic blood pressure were found, favouring allopurinol. There were insufficient data on adverse events, incidence of ESRD and cardiovascular disease for analysis.

Conclusions: Adequately powered RCTs are needed to establish whether treatments that lower urate have beneficial renal and cardiovascular effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram.
Figure 2
Figure 2
Forest plots.
Figure 3
Figure 3
Risk of bias assessment.
Figure 4
Figure 4
Funnel plot.

References

    1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–59. doi: 10.1038/sj.ki.5002343. - DOI - PubMed
    1. Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005;68(6):2801–8. doi: 10.1111/j.1523-1755.2005.00752.x. - DOI - PubMed
    1. Hajhosseiny R, Khavandi K, Goldsmith DJ. Cardiovascular disease in chronic kidney disease: untying the Gordian knot. Int J Clin Pract. 2013;67(1):14–31. doi: 10.1111/j.1742-1241.2012.02954.x. - DOI - PubMed
    1. Talbott JH, Terplan KL. The kidney in gout. Medicine (Baltimore) 1960;39:405–67. doi: 10.1097/00005792-196012000-00001. - DOI - PubMed
    1. Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD) Nephrol Dial Transplant. 2012;27(5):1847–54. doi: 10.1093/ndt/gfr561. - DOI - PubMed

Publication types

MeSH terms